C

Curative Biotechnology Inc
OTC:CUBT

Watchlist Manager
Curative Biotechnology Inc
OTC:CUBT
Watchlist
Price: 0.0072 USD -1.37%
Market Cap: $7.7m

Profitability Summary

Curative Biotechnology Inc's profitability score is 52/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

52/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

52/100
Profitability
Score
52/100
Profitability
Score

Margins

Earnings Waterfall
Curative Biotechnology Inc

Margins Comparison
Curative Biotechnology Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Curative Biotechnology Inc
OTC:CUBT
7.7m USD
Loading...
Loading...
Loading...
US
Astria Therapeutics Inc
NASDAQ:ATXS
326.4B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
206.5B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.3B EUR
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
43.4B USD
Loading...
Loading...
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
284.7B CNY
Loading...
Loading...
Loading...
DE
BioNTech SE
NASDAQ:BNTX
26.7B USD
Loading...
Loading...
Loading...
US
United Therapeutics Corp
NASDAQ:UTHR
22.1B USD
Loading...
Loading...
Loading...
BM
Roivant Sciences Ltd
NASDAQ:ROIV
20.6B USD
Loading...
Loading...
Loading...
US
Moderna Inc
NASDAQ:MRNA
20.5B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Curative Biotechnology Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Curative Biotechnology Inc
OTC:CUBT
7.7m USD
Loading...
Loading...
Loading...
Loading...
US
Astria Therapeutics Inc
NASDAQ:ATXS
326.4B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
206.5B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.3B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
43.4B USD
Loading...
Loading...
Loading...
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
284.7B CNY
Loading...
Loading...
Loading...
Loading...
DE
BioNTech SE
NASDAQ:BNTX
26.7B USD
Loading...
Loading...
Loading...
Loading...
US
United Therapeutics Corp
NASDAQ:UTHR
22.1B USD
Loading...
Loading...
Loading...
Loading...
BM
Roivant Sciences Ltd
NASDAQ:ROIV
20.6B USD
Loading...
Loading...
Loading...
Loading...
US
Moderna Inc
NASDAQ:MRNA
20.5B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Curative Biotechnology Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett